https://sel120inhibitor.com/in....fluence-involving-tp
Experimental design We examined progression-free survival (PFS) and total survival (OS) of patients with advanced-stage PDAC, who had both germline- and somatic-targeted gene sequencing. Homologous recombination gene mutations (HRm) had been examined BRCA1, BRCA2, PALB2, ATM, BAP1, BARD1, BLM, BRIP1, CHEK2, FAM175A, FANCA, FANCC, NBN, RAD50, RAD51, RAD51C, and RTEL1 HRm standing had been grouped as (i) germline versus somatic; (ii) core (BRCAs and PALB2) versus non-core (other HRm); and (iii)
Like
Comment
Share
